Enveric Biosciences Market Risk Adjusted Performance
| ENVB Stock | | | USD 1.99 0.09 4.74% |
Reference data associated with the Market Risk Adjusted Performance technical indicator for Enveric Biosciences. Some instruments may provide partial coverage depending on trading history.
Enveric Biosciences has current Market Risk Adjusted Performance of
-0.78.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.78 | |
| ER[a] | = | Expected return on investing in Enveric Biosciences |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Enveric Biosciences Market Risk Adjusted Performance Peers Comparison
Enveric Market Risk Adjusted Performance Relative To Other Indicators
Enveric Biosciences is rated
below average in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.